Kevin D. Laugero,Michael R. Hanley,Christine M. Mack,David G. Parkes,Paul McGonigle
申请号：
US13651130
公开号：
US20130035294A1
申请日:
2012.10.12
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Methods and compositions for treating psychiatric diseases and disorders are disclosed. The methods provided generally involve the administration of an NMX peptide, an FNX peptide, or an NMX receptor agonist, or analogs or derivatives thereof, to a subject in order to treat psychiatric diseases and disorders, and conditions associated with psychiatric diseases and disorders.
